Income Statement Streamline Health Solutions, Inc.

Stocks

STRM

US86323X2053

Healthcare Facilities & Services

Delayed Nasdaq 16:30:00 2025-08-11 EDT			5-day change	1st Jan Change
5.333 ^USD	-0.13%		-.--%	-

25-08-13	Streamline Health Solutions, Inc. Announces Chief Executive Officer Changes	CI
25-08-13	Streamline Health Solutions, Inc. Announces Chief Financial Officer Changes	CI

2f3beedff0617a47ddff0883.txOiQAh6tO1cNnFjeIoehJCXzQnsth93Yfb4g0NEuQs.80PVA2cT3akYcDgkS78q6Pbzj0y63l0uCoHP5At0-2_6YNoEYhXTpwQHFg

Published financial data: STREAMLINE HEALTH SOLUTIONS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	11.35M	17.38M	24.89M	22.6M	17.9M
Total Revenues	11.35M	17.38M	24.89M	22.6M	17.9M
Cost of Goods Sold, Total	5.69M	8.58M	13.4M	11.05M	9.56M
Gross Profit	5.66M	8.8M	11.49M	11.54M	8.34M
Selling General & Admin Expenses, Total	8.56M	11.93M	16.13M	14.71M	11.74M
R&D Expenses	2.93M	4.78M	6.04M	5.7M	4.63M
Other Operating Expenses, Total	11.5M	16.71M	22.18M	20.41M	16.37M
Operating Income	-5.84M	-7.91M	-10.68M	-8.87M	-8.03M
Interest Expense, Total	-51K	-236K	-749K	-1.07M	-2.01M
Net Interest Expenses	-51K	-236K	-749K	-1.07M	-2.01M
Other Non Operating Income (Expenses)	-62K	60K	201K	31K	-2K
EBT, Excl. Unusual Items	-5.95M	-8.09M	-11.23M	-9.91M	-10.04M
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-2.81M	-149K	-	-
Impairment of Goodwill	-	-	-	-9.81M	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-963K	-
Other Unusual Items	-105K	4.09M	71K	1.94M	-115K
EBT, Incl. Unusual Items	-6.06M	-6.81M	-11.31M	-18.74M	-10.16M
Income Tax Expense	-1.26M	109K	71K	-46K	-
Earnings From Continuing Operations	-4.8M	-6.92M	-11.38M	-18.7M	-10.16M
Earnings Of Discontinued Operations	5.1M	375K	-	-	-
Net Income to Company	296K	-6.54M	-11.38M	-18.7M	-10.16M
Net Income - (IS)	296K	-6.54M	-11.38M	-18.7M	-10.16M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	296K	-6.54M	-11.38M	-18.7M	-10.16M
Net Income to Common Excl. Extra Items	-4.8M	-6.92M	-11.38M	-18.7M	-10.16M
Per Share Items
Net EPS - Basic	0.15	-2.29	-3.46	-4.96	-2.53
Basic EPS - Continuing Operations	-2.39	-2.42	-3.46	-4.96	-2.53
Basic Weighted Average Shares Outstanding	2.01M	2.85M	3.29M	3.77M	4.01M
Net EPS - Diluted	0.09	-2.29	-3.46	-4.96	-2.53
Diluted EPS - Continuing Operations	-2.4	-2.42	-3.46	-4.96	-2.53
Diluted Weighted Average Shares Outstanding	2.04M	2.88M	3.29M	3.77M	4.01M
Normalized Basic EPS	-1.85	-1.77	-2.13	-1.64	-1.57
Normalized Diluted EPS	-1.82	-1.75	-2.13	-1.64	-1.57
Supplemental Items
EBITDA	-5.29M	-6.89M	-9.29M	-7.67M	-6.55M
EBITA	-5.35M	-6.96M	-9.34M	-7.72M	-6.59M
EBIT	-5.84M	-7.91M	-10.68M	-8.87M	-8.03M
EBITDAR	-5.07M	-6.95M	-9.09M	-7.67M	-
Total Revenues (As Reported)	11.35M	17.38M	24.89M	22.6M	17.9M
Effective Tax Rate - (Ratio)	20.8	-1.6	-0.63	0.25	-
Current Domestic Taxes	-1.26M	14K	62K	58K	-
Total Current Taxes	-1.26M	14K	62K	58K	-
Deferred Domestic Taxes	-	95K	9K	-104K	-
Total Deferred Taxes	-	95K	9K	-104K	-
Normalized Net Income	-3.72M	-5.05M	-7.02M	-6.19M	-6.28M
Interest Capitalized	-	-	-	-	34K
Interest on Long-Term Debt	51K	236K	749K	1.07M	2.01M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	4.6M	6.63M	8.46M	8.17M	7.27M
Net Rental Expense, Total	212K	-64K	194K	-1K	-
Imputed Operating Lease Interest Expense	26.24K	-18.79K	117K	-844	-
Imputed Operating Lease Depreciation	186K	-45.21K	77.11K	-156	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	1.4M	2.22M	1.68M	2.1M	1.96M
Total Stock-Based Compensation	1.4M	2.22M	1.68M	2.1M	1.96M

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	2.41M	9.88M	6.6M	3.19M	2.18M
Total Cash And Short Term Investments	2.41M	9.88M	6.6M	3.19M	2.18M
Accounts Receivable, Total	3.1M	4.67M	8.68M	5.02M	3.16M
Total Receivables	3.1M	4.67M	8.68M	5.02M	3.16M
Prepaid Expenses	416K	568K	710K	629K	438K
Other Current Assets, Total	1.39M	-	-	-	-
Total Current Assets	7.32M	15.12M	15.99M	8.84M	5.78M
Gross Property Plant And Equipment	947K	533K	357K	379K	159K
Accumulated Depreciation	-452K	-192K	-246K	-291K	-110K
Net Property Plant And Equipment	495K	341K	111K	88K	49K
Goodwill	10.71M	23.09M	23.09M	13.28M	13.28M
Other Intangibles, Total	6.57M	22.32M	20.64M	17.87M	15.28M
Accounts Receivable Long-Term	-	-	-	-	-
Deferred Charges Long-Term	666K	806K	1.53M	1.46M	1.13M
Other Long-Term Assets, Total	220K	142K	161K	205K	65K
Total Assets	25.98M	61.82M	61.52M	41.74M	35.58M
Liabilities
Accounts Payable, Total	272K	778K	626K	1.25M	1.54M
Accrued Expenses, Total	908K	1.8M	3.26M	2.02M	1.92M
Current Portion of Long-Term Debt	1.53M	250K	750K	1.5M	13.12M
Current Portion of Leases	198K	204K	35K	-	-
Unearned Revenue Current, Total	3.86M	5.79M	8.36M	7.11M	6.1M
Other Current Liabilities	595K	4.67M	3.74M	1.79M	377K
Total Current Liabilities	7.37M	13.5M	16.78M	13.68M	23.06M
Long-Term Debt	767K	9.65M	8.96M	9.07M	-
Long-Term Leases	222K	33K	-	-	-
Unearned Revenue Non Current	130K	136K	167K	173K	240K
Other Non Current Liabilities	-	4.45M	104K	-	-
Total Liabilities	8.49M	27.77M	26.01M	22.92M	23.3M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	316K	478K	576K	590K	43K
Additional Paid In Capital	96.29M	119M	132M	134M	138M
Retained Earnings	-79.12M	-85.66M	-97.04M	-116M	-126M
Total Common Equity	17.49M	34.04M	35.51M	18.81M	12.28M
Total Equity	17.49M	34.04M	35.51M	18.81M	12.28M
Total Liabilities And Equity	25.98M	61.82M	61.52M	41.74M	35.58M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.76M	3.14M	3.78M	4.23M	4.12M
ECS Total Common Shares Outstanding	2.04M	3.12M	3.71M	3.8M	4.05M
Book Value / Share	8.55	10.91	9.56	4.95	3.03
Tangible Book Value	208K	-11.36M	-8.22M	-12.33M	-16.28M
Tangible Book Value Per Share	0.1	-3.64	-2.21	-3.25	-4.02
Total Debt	2.72M	10.14M	9.75M	10.57M	13.12M
Net Debt	312K	256K	3.15M	7.38M	10.94M
Debt Equivalent Oper. Leases	1.7M	-512K	1.55M	-8K	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	-	-	-	-
Full Time Employees	66	134	112	77	70
Part Time Employees	1	-	-	-	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	65K	76K	132K	86K	59K
Order Backlog	-	-	-	-	-

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	296K	-6.54M	-11.38M	-18.7M	-10.16M
Depreciation & Amortization - CF	64K	68K	54K	45K	46K
Amortization of Goodwill and Intangible Assets - (CF)	491K	956K	1.34M	1.15M	1.44M
Depreciation & Amortization, Total	555K	1.02M	1.4M	1.2M	1.48M
Amortization of Deferred Charges, Total - (CF)	2.02M	2.67M	2.92M	3.13M	3.37M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Asset Writedown & Restructuring Costs	31K	-1.85M	-	10.78M	-
Stock-Based Compensation (CF)	1.4M	2.22M	1.68M	2.1M	1.96M
Provision and Write-off of Bad Debts	-31K	11K	189K	-10K	-58K
Net Cash From Discontinued Operations	-2.26M	380K	-	-	-
Other Operating Activities, Total	-6.26M	-2.56M	-62K	-2.05M	810K
Change In Accounts Receivable	-253K	-129K	-4.2M	3.71M	1.92M
Change In Accounts Payable	-484K	17K	-152K	544K	288K
Change in Unearned Revenues	344K	1.07M	2.6M	-1.24M	-946K
Change in Other Net Operating Assets	-1.11M	187K	-128K	-1.68M	-183K
Cash from Operations	-5.76M	-3.5M	-7.14M	-2.22M	-1.51M
Capital Expenditure	-44K	-41K	-10K	-54K	-7K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-12.47M	-	-	-
Divestitures	11.29M	-	-	-	-
Sale (Purchase) of Intangible assets	-1.78M	-1.46M	-1.92M	-1.57M	-851K
Other Investing Activities, Total	-	800K	-	-	-
Cash from Investing	9.46M	-13.17M	-1.94M	-1.62M	-858K
Long-Term Debt Issued, Total	2.3M	10M	-	1.5M	5.4M
Total Debt Issued	2.3M	10M	-	1.5M	5.4M
Long-Term Debt Repaid, Total	-4M	-	-250K	-750K	-3M
Total Debt Repaid	-4M	-	-250K	-750K	-3M
Issuance of Common Stock	-	16.1M	8.32M	-	100K
Repurchase of Common Stock	-	-	-	-	-81K
Repurchase of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-1.24M	-1.95M	-2.28M	-322K	-1.05M
Cash from Financing	-2.94M	24.15M	5.79M	428K	1.36M
Net Change in Cash	760K	7.48M	-3.29M	-3.41M	-1.01M
Supplemental Items
Cash Interest Paid	17K	153K	651K	989K	834K
Cash Income Tax Paid (Refund)	-	21K	23K	66K	45K
Levered Free Cash Flow	-7.66M	6.4M	-4.3M	-1.47M	-511K
Unlevered Free Cash Flow	-7.63M	6.5M	-3.83M	-797K	747K
Change In Net Working Capital	6.13M	-7.08M	1.21M	65K	192K
Net Debt Issued / Repaid	-1.7M	10M	-250K	750K	2.4M

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-12.66	-11.26	-10.83	-10.74	-12.98
Return on Total Capital	-18.21	-15.36	-14.93	-14.86	-18.32
Return On Equity %	-28.66	-26.84	-32.72	-68.83	-65.35
Return on Common Equity	-28.66	-26.84	-32.72	-68.83	-65.35
Margin Analysis
Gross Profit Margin %	49.86	50.65	46.18	51.08	46.58
SG&A Margin	75.49	68.65	64.82	65.1	65.58
EBITDA Margin %	-46.59	-39.63	-37.31	-33.96	-36.58
EBITA Margin %	-47.15	-40.02	-37.53	-34.16	-36.84
EBIT Margin %	-51.48	-45.52	-42.92	-39.26	-44.85
Income From Continuing Operations Margin %	-42.3	-39.8	-45.72	-82.74	-56.75
Net Income Margin %	2.61	-37.64	-45.72	-82.74	-56.75
Net Avail. For Common Margin %	-42.3	-39.8	-45.72	-82.74	-56.75
Normalized Net Income Margin	-32.8	-29.08	-28.2	-27.41	-35.07
Levered Free Cash Flow Margin	-67.53	36.85	-17.27	-6.49	-2.86
Unlevered Free Cash Flow Margin	-67.24	37.4	-15.39	-3.53	4.17
Asset Turnover
Asset Turnover	0.39	0.4	0.4	0.44	0.46
Fixed Assets Turnover	38.27	41.58	110.13	227.1	261.33
Receivables Turnover (Average Receivables)	3.83	4.47	3.73	3.3	4.38
Short Term Liquidity
Current Ratio	0.99	1.12	0.95	0.65	0.25
Quick Ratio	0.75	1.08	0.91	0.6	0.23
Operating Cash Flow to Current Liabilities	-0.78	-0.26	-0.43	-0.16	-0.07
Days Sales Outstanding (Average Receivables)	95.52	81.58	97.85	110.62	83.55
Average Days Payable Outstanding	33.07	22.34	19.13	31.02	53.47
Long Term Solvency
Total Debt/Equity	15.56	29.79	27.45	56.16	106.9
Total Debt / Total Capital	13.46	22.95	21.54	35.96	51.67
LT Debt/Equity	5.65	28.45	25.24	48.19	-
Long-Term Debt / Total Capital	4.89	21.92	19.81	30.86	-
Total Liabilities / Total Assets	32.68	44.93	42.28	54.92	65.49
EBIT / Interest Expense	-114.53	-33.52	-14.26	-8.28	-3.99
EBITDA / Interest Expense	-99.49	-28.36	-12.14	-7.16	-3.25
(EBITDA - Capex) / Interest Expense	-100.35	-28.54	-12.15	-7.21	-3.26
Total Debt / EBITDA	-0.54	-1.52	-1.07	-1.38	-2
Net Debt / EBITDA	-0.06	-0.04	-0.35	-0.96	-1.67
Total Debt / (EBITDA - Capex)	-0.53	-1.51	-1.07	-1.37	-2
Net Debt / (EBITDA - Capex)	-0.06	-0.04	-0.35	-0.95	-1.67
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.28	53.17	43.21	-9.21	-20.78
Gross Profit, 1 Yr. Growth %	-13	55.59	30.58	0.43	-27.76
EBITDA, 1 Yr. Growth %	1.71	30.29	34.83	-18.68	-14.66
EBITA, 1 Yr. Growth %	2.1	30	34.29	-18.66	-14.56
EBIT, 1 Yr. Growth %	0.81	35.44	35.03	-18.1	-9.49
Earnings From Cont. Operations, 1 Yr. Growth %	-23.14	44.13	64.51	64.31	-45.67
Net Income, 1 Yr. Growth %	-110.34	-2.31K	73.94	64.31	-45.67
Normalized Net Income, 1 Yr. Growth %	-9.09	35.82	38.86	-12.9	1.34
Diluted EPS Before Extra, 1 Yr. Growth %	-35.73	0.97	42.8	43.42	-48.94
Accounts Receivable, 1 Yr. Growth %	10.07	50.37	86.01	-42.19	-37.09
Net Property, Plant and Equip., 1 Yr. Growth %	405.1	-31.11	-67.45	-20.72	-44.32
Total Assets, 1 Yr. Growth %	-18.05	137.96	-0.48	-32.16	-14.75
Tangible Book Value, 1 Yr. Growth %	-112.97	-5.56K	-27.69	50.07	32.06
Common Equity, 1 Yr. Growth %	9.27	94.66	4.31	-47.02	-34.75
Cash From Operations, 1 Yr. Growth %	71.86K	-39.14	103.85	-68.99	-31.65
Capital Expenditures, 1 Yr. Growth %	-15.38	-6.82	-75.61	440	-87.04
Levered Free Cash Flow, 1 Yr. Growth %	196.68	-183.59	-167.12	-66.6	-65.14
Unlevered Free Cash Flow, 1 Yr. Growth %	219.33	-185.2	-158.92	-79.68	-193.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-28.77	21.09	48.11	14.03	-15.19
Gross Profit, 2 Yr. CAGR %	-36.94	16.35	42.54	14.52	-14.82
EBITDA, 2 Yr. CAGR %	157.05	15.12	32.54	5.55	-16.69
EBITA, 2 Yr. CAGR %	290.97	15.21	32.13	5.34	-16.64
EBIT, 2 Yr. CAGR %	215.45	16.85	35.23	5.89	-13.9
Earnings From Cont. Operations, 2 Yr. CAGR %	-9.54	5.25	53.98	64.41	-5.51
Net Income, 2 Yr. CAGR %	-77.53	51.16	520.02	69.06	-5.51
Normalized Net Income, 2 Yr. CAGR %	127.54	11.12	37.34	10.7	-6.05
Diluted EPS Before Extra, 2 Yr. CAGR %	-26.99	-19.44	20.08	43.11	-14.42
Accounts Receivable, 2 Yr. CAGR %	-14.01	28.65	67.24	3.69	-39.7
Net Property, Plant and Equip., 2 Yr. CAGR %	44.52	86.54	-52.65	-49.2	-33.56
Total Assets, 2 Yr. CAGR %	-9.53	39.65	53.89	-17.83	-23.95
Tangible Book Value, 2 Yr. CAGR %	-88.84	166.16	528.53	4.17	40.77
Common Equity, 2 Yr. CAGR %	67.93	45.85	42.49	-25.66	-41.2
Cash From Operations, 2 Yr. CAGR %	103	1.99K	11.39	-20.49	-53.96
Capital Expenditures, 2 Yr. CAGR %	44.75	-11.2	-52.33	14.76	-16.33
Levered Free Cash Flow, 2 Yr. CAGR %	329.09	57.48	-25.1	-52.14	-65.88
Unlevered Free Cash Flow, 2 Yr. CAGR %	241	64.95	-29.15	-64.98	-56.37
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-22.46	-8.06	28.05	25.81	0.99
Gross Profit, 3 Yr. CAGR %	-26.36	-14.79	20.91	26.84	-1.79
EBITDA, 3 Yr. CAGR %	97.42	104.95	21.35	13.23	-1.67
EBITA, 3 Yr. CAGR %	54.14	170.86	21.25	12.99	-1.76
EBIT, 3 Yr. CAGR %	30.6	137.97	22.62	14.95	0.49
Earnings From Cont. Operations, 3 Yr. CAGR %	15.69	5.65	22.15	57.35	13.67
Net Income, 3 Yr. CAGR %	-54.29	3.71	58.4	298.25	15.8
Normalized Net Income, 3 Yr. CAGR %	23.01	91.59	19.69	18.51	7.49
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.48	-18.65	-2.5	27.4	1.5
Accounts Receivable, 3 Yr. CAGR %	-1.28	3.6	45.48	17.37	-12.22
Net Property, Plant and Equip., 3 Yr. CAGR %	-24.76	12.89	4.24	-43.77	-47.62
Total Assets, 3 Yr. CAGR %	-11.23	24.88	24.74	17.12	-16.82
Tangible Book Value, 3 Yr. CAGR %	-76.4	-12.05	72.39	289.92	12.74
Common Equity, 3 Yr. CAGR %	21.08	76.4	30.43	2.46	-28.82
Cash From Operations, 3 Yr. CAGR %	41.52	35.87	862.93	-27.27	-24.4
Capital Expenditures, 3 Yr. CAGR %	-3.52	24.98	-42.28	7.06	-44.52
Levered Free Cash Flow, 3 Yr. CAGR %	62.01	148.74	18.51	-42.37	-56.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	53.78	114.78	17.04	-52.9	-51.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-16.72	-8.48	0.45	0.21	8.6
Gross Profit, 5 Yr. CAGR %	-19.67	-10.74	-4.09	-4.1	5.1
EBITDA, 5 Yr. CAGR %	11.76	25.59	68.34	57.17	4.73
EBITA, 5 Yr. CAGR %	4.58	16.05	44.92	85.65	4.7
EBIT, 5 Yr. CAGR %	0.77	11.22	32.44	72.13	6.74
Earnings From Cont. Operations, 5 Yr. CAGR %	2.27	6.03	29.71	26.1	10.22
Net Income, 5 Yr. CAGR %	-41.42	4.85	29.71	26.1	28.83
Normalized Net Income, 5 Yr. CAGR %	3.42	9.87	28.55	53.85	8.93
Diluted EPS Before Extra, 5 Yr. CAGR %	-11.87	-12.22	7.28	1.97	-7.46
Accounts Receivable, 5 Yr. CAGR %	-6.4	-1.2	21.9	3.64	2.28
Net Property, Plant and Equip., 5 Yr. CAGR %	-27.4	-29.1	-37.48	-17.97	-12.94
Total Assets, 5 Yr. CAGR %	-12.23	8.22	10.63	5.63	2.34
Tangible Book Value, 5 Yr. CAGR %	-57.18	-5.75	-12.29	-5.89	58.97
Common Equity, 5 Yr. CAGR %	1.76	23.52	29.23	24.85	-5.17
Cash From Operations, 5 Yr. CAGR %	-0.42	28.29	28.6	9.66	185.37
Capital Expenditures, 5 Yr. CAGR %	-38.94	-39.5	-27.23	20.79	-33.04
Levered Free Cash Flow, 5 Yr. CAGR %	1.35	50.8	19	28.65	-27.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.23	41.67	12.8	3.98	-20.75